Ahead of the 2015 AACR Annual Meeting we discuss how insulin resistance relates to current cancer therapies.
Michael Pollak, MD
Advertisement
Articles by Michael Pollak, MD
Advertisement
Latest Updated Articles
AACR: Insulin Signaling and Cancer Development, ProgressionPublished: April 17th 2015 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Pertuzumab Biosimilar in Breast Cancer Indications
2
FDA Approves Ziftomenib in R/R NPM1-Mutated Acute Myeloid Leukemia
3
Scorpion Venom Approach May Prove “Powerful” in Glioblastoma Research
4
FDA Approves Diagnostic Tool for Pembrolizumab Combo in Endometrial Cancer
5
